Clinical Trial Update: F573 for Injection for the Treatment of Liver Injury/Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for F573 for Injection in acute liver failure and acute-on-chronic liver failure, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure
• On Chronic Liver Failure

Drugs mentioned

• F573 for Injection

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Acute Liver Failure, Acute-On-Chronic Liver Failure | Phase 2 | Status: RECRUITING